Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Custom Search Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
| EDIT | Editas Medicine, Inc. | -518.00 | $3.42 | -$1.77K | Sep 6, 2024 | Sale | -0.39% | 133.90K | EVP, CHIEF MEDICAL OFFICER | Sep 4 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -1.55K | $3.42 | -$5.33K | Sep 6, 2024 | Sale | -0.49% | 313.72K | CEO | Sep 4 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -11.89K | $5.42 | -$64.37K | Jul 26, 2024 | Sale | -13.98% | 73.14K | EVP, CHIEF SCIENTIFIC OFFICER | Jul 25 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -6.62K | $5.21 | -$34.46K | Jul 22, 2024 | Sale | -4.69% | 134.41K | EVP, CHIEF MEDICAL OFFICER | Jul 19 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -12.19K | $5.50 | -$67.00K | Jun 6, 2024 | Sale | -3.72% | 315.28K | CEO | Jun 4 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -511.00 | $5.50 | -$2.81K | Jun 6, 2024 | Sale | -0.36% | 141.03K | EVP, CHIEF MEDICAL OFFICER | Jun 4 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 3, 2024 | Grant | — | 25.00K | — | May 30 | — | View | |
| EDIT | Editas Medicine, Inc. | -22.34K | $5.61 | -$125.40K | May 22, 2024 | Sale | -16.05% | 116.83K | EVP, CHIEF FINANCIAL OFFICER | May 20 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | 45.00K | $5.64 | $253.87K | May 14, 2024 | Purchase | 198.24% | 67.70K | — | May 13 | — | View | |
| EDIT | Editas Medicine, Inc. | 167.27K | — | — | Mar 5, 2024 | Grant | 214.72% | 245.17K | EVP, CHIEF FINANCIAL OFFICER | Mar 2 | — | View | |
| EDIT | Editas Medicine, Inc. | 114.25K | — | — | Mar 5, 2024 | Grant | 252.96% | 159.42K | EVP, CHIEF SCIENTIFIC OFFICER | Mar 2 | — | View | |
| EDIT | Editas Medicine, Inc. | 589.40K | $9.42 | -$732.88K | Mar 5, 2024 | Grant | 452.80% | 719.57K | CEO | Mar 2 - Mar 5 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | 222.29K | $9.42 | -$191.43K | Mar 5, 2024 | Grant | 308.50% | 294.34K | SVP, CHIEF MEDICAL OFFICER | Mar 2 - Mar 4 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -103.00 | $10.90 | -$1.12K | Dec 7, 2023 | Sale | -0.14% | 74.79K | EVP, CBO AND CTO | Dec 5 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -695.00 | $8.21 | -$5.71K | Nov 16, 2023 | Sale | -0.92% | 74.89K | EVP, CBO AND CTO | Nov 14 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -139.00 | $8.40 | -$1.17K | Nov 9, 2023 | Sale | -0.18% | 75.59K | EVP, CBO AND CTO | Nov 7 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | -103.00 | $8.82 | -$908.46 | Sep 7, 2023 | Sale | -0.14% | 75.73K | EVP, CBO AND CTO | Sep 6 | — | View | |
| EDIT | Editas Medicine, Inc. | -702.00 | $8.59 | -$6.03K | Aug 15, 2023 | Sale | -0.92% | 75.83K | EVP, CBO AND CTO | Aug 11 | — | View | |
| EDIT | Editas Medicine, Inc. | -141.00 | $8.39 | -$1.18K | Aug 10, 2023 | Sale | -0.18% | 76.53K | EVP, CBO AND CTO | Aug 8 | — | View | |
| EDIT | Editas Medicine, Inc. | 180.67K | — | — | Jul 25, 2023 | Grant | — | 180.67K | EVP, CHIEF SCIENTIFIC OFFICER | Jul 24 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Jul 25, 2023 | — | — | — | EVP, CHIEF SCIENTIFIC OFFICER | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -4.32K | $8.80 | -$37.99K | Jul 21, 2023 | Sale | -5.65% | 72.06K | SVP, CHIEF MEDICAL OFFICER | Jul 19 | — | View | |
| EDIT | Editas Medicine, Inc. | -6.49K | $9.50 | -$61.64K | Jun 7, 2023 | Sale | -4.75% | 130.17K | CEO | Jun 5 | — | View | |
| EDIT | Editas Medicine, Inc. | -105.00 | $9.50 | -$997.81 | Jun 7, 2023 | Sale | -0.14% | 76.67K | EVP, CBO AND CTO | Jun 5 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 5, 2023 | Grant | — | 25.00K | — | Jun 1 | — | View | |
| EDIT | Editas Medicine, Inc. | 233.70K | — | — | May 18, 2023 | Grant | — | 233.70K | EVP, CHIEF FINANCIAL OFFICER | May 17 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | May 18, 2023 | — | — | — | EVP, CHIEF FINANCIAL OFFICER | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -949.00 | $9.87 | -$9.37K | May 15, 2023 | Sale | -0.88% | 106.61K | EVP, CHIEF FINANCIAL OFFICER | May 11 | — | View | |
| EDIT | Editas Medicine, Inc. | -668.00 | $9.87 | -$6.59K | May 15, 2023 | Sale | -0.86% | 76.78K | EVP, CBO AND CTO | May 11 | — | View | |
| EDIT | Editas Medicine, Inc. | -135.00 | $9.51 | -$1.28K | May 11, 2023 | Sale | -0.17% | 77.45K | EVP, CBO AND CTO | May 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 50.00K | — | — | Apr 13, 2023 | Grant | — | 50.00K | — | Apr 11 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Apr 13, 2023 | — | — | — | — | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | 125.82K | $8.89 | -$1.64K | Mar 6, 2023 | Grant | 165.02% | 202.06K | EVP, CHIEF FINANCIAL OFFICER | Mar 2 - Mar 3 | — | View | |
| EDIT | Editas Medicine, Inc. | 72.00K | — | — | Mar 6, 2023 | Grant | 123.35% | 130.37K | SVP, CHIEF MEDICAL OFFICER | Mar 2 | — | View | |
| EDIT | Editas Medicine, Inc. | 200.00K | — | — | Mar 6, 2023 | Grant | 230.80% | 286.66K | CEO | Mar 2 | — | View | |
| EDIT | Editas Medicine, Inc. | 66.60K | $8.89 | -$897.89 | Mar 6, 2023 | Grant | 109.21% | 127.58K | EVP, CBO AND CTO | Mar 2 - Mar 3 | — | View | |
| EDIT | Editas Medicine, Inc. | -2.79K | $9.67 | -$26.97K | Feb 15, 2023 | Sale | -4.08% | 65.56K | EVP, CHIEF SCIENTIFIC OFFICER | Feb 13 | — | View | |
| EDIT | Editas Medicine, Inc. | -4.29K | $9.67 | -$41.44K | Feb 15, 2023 | Sale | -5.32% | 76.24K | EVP, CHIEF FINANCIAL OFFICER | Feb 13 | — | View | |
| EDIT | Editas Medicine, Inc. | -3.31K | $9.67 | -$31.96K | Feb 15, 2023 | Sale | -5.14% | 60.98K | EVP, CBO AND CTO | Feb 13 | — | View | |
| EDIT | Editas Medicine, Inc. | -346.00 | $11.10 | -$3.84K | Feb 9, 2023 | Sale | -0.54% | 64.29K | EVP, CBO AND CTO | Feb 7 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.75K | $8.16 | -$14.30K | Jan 12, 2023 | Sale | -2.13% | 80.53K | EVP, CHIEF FINANCIAL OFFICER | Jan 10 | — | View | |
| EDIT | Editas Medicine, Inc. | -193.00 | $10.23 | -$1.97K | Dec 6, 2022 | Sale | -0.23% | 82.28K | EVP, CHIEF FINANCIAL OFFICER | Dec 5 | — | View | |
| EDIT | Editas Medicine, Inc. | -102.00 | $10.23 | -$1.04K | Dec 6, 2022 | Sale | -0.16% | 64.64K | EVP, CHIEF BUSINESS OFFICER | Dec 5 | — | View | |
| EDIT | Editas Medicine, Inc. | -289.00 | $11.02 | -$3.18K | Nov 9, 2022 | Sale | -0.44% | 64.74K | EVP, CHIEF BUSINESS OFFICER | Nov 8 | — | View | |
| EDIT | Editas Medicine, Inc. | -192.00 | $15.01 | -$2.88K | Sep 8, 2022 | Sale | -0.23% | 82.48K | EVP, CHIEF FINANCIAL OFFICER | Sep 6 | — | View | |
| EDIT | Editas Medicine, Inc. | -101.00 | $15.01 | -$1.52K | Sep 8, 2022 | Sale | -0.16% | 65.03K | EVP, CHIEF BUSINESS OFFICER | Sep 6 | — | View | |
| EDIT | Editas Medicine, Inc. | -293.00 | $18.60 | -$5.45K | Aug 10, 2022 | Sale | -0.45% | 65.13K | EVP, CHIEF BUSINESS OFFICER | Aug 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 229.97K | — | — | Jul 20, 2022 | Grant | — | 229.97K | SVP, CHIEF MEDICAL OFFICER | Jul 18 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Jul 20, 2022 | — | — | — | SVP, CHIEF MEDICAL OFFICER | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -5.14K | $10.06 | -$51.74K | Jun 16, 2022 | Sale | -7.00% | 68.35K | EVP, CHIEF SCIENTIFIC OFFICER | Jun 15 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 25.00K | — | — | Jun 13, 2022 | Grant | — | 25.00K | — | Jun 9 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.12K | $11.54 | -$12.96K | Jun 6, 2022 | Sale | -1.69% | 65.42K | EVP, CHIEF BUSINESS OFFICER | Jun 3 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.53K | $11.54 | -$17.62K | Jun 6, 2022 | Sale | -1.81% | 82.67K | EVP, CHIEF FINANCIAL OFFICER | Jun 3 | — | View | |
| EDIT | Editas Medicine, Inc. | 1.04M | — | — | Jun 6, 2022 | Grant | — | 1.04M | CEO | Jun 2 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Jun 6, 2022 | — | — | — | CEO | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -297.00 | $13.11 | -$3.89K | May 11, 2022 | Sale | -0.44% | 66.54K | EVP, CHIEF BUSINESS OFFICER | May 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 170.99K | — | — | Apr 18, 2022 | Grant | — | 170.99K | CEO | Apr 14 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.54K | $26.61 | -$41.12K | Apr 4, 2022 | Sale | -2.26% | 66.84K | EVP, CHIEF BUSINESS OFFICER | Aug 9 - Apr 1 | — | View | |
| EDIT | Editas Medicine, Inc. | -403.00 | $17.33 | -$6.98K | Mar 7, 2022 | Sale | -0.59% | 68.39K | EVP, CHIEF BUSINESS OFFICER | Mar 3 | — | View | |
| EDIT | Editas Medicine, Inc. | -767.00 | $17.33 | -$13.29K | Mar 7, 2022 | Sale | -0.90% | 84.19K | EVP, CHIEF FINANCIAL OFFICER | Mar 3 | — | View | |
| EDIT | Editas Medicine, Inc. | 148.32K | — | — | Feb 11, 2022 | Grant | 475.46% | 179.52K | EVP, CHIEF BUSINESS OFFICER | Feb 10 | — | View | |
| EDIT | Editas Medicine, Inc. | 125.11K | — | — | Feb 11, 2022 | Grant | 299.41% | 166.89K | EVP, CHIEF SCIENTIFIC OFFICER | Feb 10 | — | View | |
| EDIT | Editas Medicine, Inc. | 211.08K | — | — | Feb 11, 2022 | Grant | 670.90% | 242.54K | CHIEF FINANCIAL OFFICER | Feb 10 | — | View | |
| EDIT | Editas Medicine, Inc. | -302.00 | $17.63 | -$5.32K | Feb 10, 2022 | Sale | -0.96% | 31.20K | EVP, CHIEF BUSINESS OFFICER | Feb 8 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.74K | $25.70 | -$44.82K | Jan 13, 2022 | Sale | -5.25% | 31.46K | Chief Financial Officer | Jan 11 | — | View | |
| EDIT | Editas Medicine, Inc. | -18.25K | $26.95 | -$491.98K | Jan 4, 2022 | Sale | -19.39% | 75.90K | CEO | Jan 3 | — | View | |
| EDIT | Editas Medicine, Inc. | 3.47K | — | — | Dec 23, 2021 | Grant | 12.39% | 31.50K | EVP, Chief Business Officer | Dec 22 | — | View | |
| EDIT | Editas Medicine, Inc. | 4.24K | — | — | Dec 23, 2021 | Grant | 23.02% | 22.68K | EVP/Chief Medical Officer | Dec 22 | — | View | |
| EDIT | Editas Medicine, Inc. | 9.08K | — | — | Dec 23, 2021 | Grant | 27.78% | 41.79K | EVP, Chief Scientific Officer | Dec 22 | — | View | |
| EDIT | Editas Medicine, Inc. | 4.47K | — | — | Dec 23, 2021 | Grant | 15.56% | 33.21K | Chief Financial Officer | Dec 22 | — | View | |
| EDIT | Editas Medicine, Inc. | 36.48K | — | — | Dec 23, 2021 | Grant | 63.25% | 94.15K | CEO | Dec 22 | — | View | |
| EDIT | Editas Medicine, Inc. | -1.57K | $38.33 | -$60.10K | Nov 15, 2021 | Sale | -7.84% | 18.43K | EVP/Chief Medical Officer | Nov 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -287.00 | $40.61 | -$11.66K | Nov 10, 2021 | Sale | -1.01% | 28.03K | EVP, Chief Business Officer | Nov 9 | — | View | |
| EDIT | Editas Medicine, Inc. | 24.73K | — | — | Oct 28, 2021 | Grant | — | 24.73K | — | Oct 26 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Oct 28, 2021 | — | — | — | — | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -13.80K | $38.03 | -$525.03K | Oct 20, 2021 | Sale | -19.31% | 57.67K | CEO | Oct 18 | — | View | |
| EDIT | Editas Medicine, Inc. | 36.48K | — | — | Oct 4, 2021 | Grant | 104.22% | 71.48K | CEO | Sep 30 | — | View | |
| EDIT | Editas Medicine, Inc. | 13.74K | — | — | Sep 8, 2021 | Grant | — | 13.74K | — | Sep 3 | — | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Sep 8, 2021 | — | — | — | — | Jan 12 | — | View | |
| EDIT | Editas Medicine, Inc. | -2.50K | $45.33 | -$73.37K | Aug 10, 2021 | Sale | -1.71% | 143.74K | Chief Financial Officer | Aug 9 | Scheduled | View | |
| EDIT | Editas Medicine, Inc. | — | — | — | Jul 30, 2021 | — | — | 28.31K | EVP, Chief Business Officer | Jan 12 | — | View |
Showing a maximum of 100 results
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved